Office of Medical Communications

Leaders at the University of Vermont and Larner College of Medicine announced $12.3 million in funding for a new Center of Biomedical Research Excellence (COBRE) called the “Translational Global Infectious Disease Research Center” (TGIR) that will join together two traditionally distinct groups of scientists to develop innovative approaches to prevent and control infectious disease.

An innovative initiative that will use a public health approach to inform opioid prescribing policies will be launched in northern New England thanks to a new $339,000 grant to the Northern New England Clinical and Translational Research (NNE-CTR) Network from the National Institutes of Health.

The UVM Larner College of Medicine's Class of 2022 received their first doctors' white coats on Friday, October 5 at the University of Vermont's Ira Allen Chapel.

Comments by Assistant Professor of Surgery and UVM Cancer Center member Thomas Ahern, Ph.D., are featured in a CNN.com article, titled “Statins' benefits beyond heart health aren't clear-cut, analysis says.”

In honor of September being Prostate Cancer Awareness month, Mark Plante, M.D. UVM associate professor of surgery, spoke with WCAX about why prostate cancer diagnoses are going down.

An $11.7 million Center of Biomedical Research Excellence (COBRE) grant renewal to the Vermont Center on Behavior and Health (VCBH) at the University of Vermont will support another five years of research on addressing and better understanding the unhealthy behaviors that negatively impact health and cost the U.S. healthcare system billions of dollars.

Three innovative projects spanning the fields of regenerative medicine, electrophysiology, and infectious diseases were selected to receive SPARK-VT research funding following a June 22 proposal presentation meeting at which University of Vermont faculty applicants pitched ideas to a panel of consultants from the biomedical and biotech arena. The awardees include UVM Larner College of Medicine Department of Medicine faculty members Daniel Weiss, M.D., Ph.D., Jason Botten, Ph.D., and Peter Spector, M.D.

Harvey J. Grill, Ph.D., presented the Annual Stetson Lecture in Technological Advances in Medicine on Friday, September 14, 2018 in the UVM Davis Center’s Silver Maple Ballroom. Grill, a professor of behavioral neuroscience at the University of Pennsylvania and director of the Obesity Unit at the Institute of Diabetes, Obesity and Metabolism, discussed “Treating the Hyperphagia Driving Obesity: Neural Mechanisms of Feeding Inhibition.”

Although malnutrition is a serious concern associated with adverse outcomes and cost, no single existing approach to malnutrition diagnosis has achieved broad global acceptance. Now, thanks to more than two years’ work by members of the Global Leadership Initiative on Malnutrition (GLIM) working group, a consensus report, which outlines five criteria for malnutrition, has just been published in the latest issue of both the Journal of Parenteral and Enteral Nutrition and Clinical Nutrition.

(SEPTEMBER 4, 2018) This summer, University of Vermont Larner College of Medicine medical student Hanaa Shihadeh '21 had a chance to see her native country of Jordan through a different set of eyes - those of a Syrian American Medical Society (SAMS) volunteer.

Helene Langevin, M.D., C.M., a visiting professor of neurological sciences at the Larner College of Medicine at the University of Vermont and director of the Osher Center for Integrative Medicine at Brigham and Women's Hospital and Harvard Medical School, has been named director of the National Center for Complementary and Integrative Health.

The United States Department of Defense published an online article about Arti Shukla's, Ph.D., UVM associate professor of pathology and laboratory medicine, research study regarding the role of exosomes in the development of mesothelioma.

UVM Assistant Professor of Anesthesiology Melissa Covington, M.D. was interviewed by the Boston Globe to discuss the results of recent studies relating to opioid prescribing practices.

More than 150 people gathered for a formal investiture ceremony honoring the University of Vermont’s newest endowed faculty members and recognizing the donors who made the positions possible on August 21, 2018 at the UVM Alumni House. Michael LaMantia, M.D., M.P.H., was invested as the inaugural Holly and Bob Miller Chair in Memory and Aging and Rosemary Dale, Ed.D., A.P.R.N., was invested as the first Holly and Bob Miller Professor in Nursing Leadership.

On Thursday, August 16, the National Institute of Allergy and Infectious Diseases (NIAID) announced that vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

Kathryn Huggett, Ph.D., director of the Teaching Academy at the Larner College of Medicine at the University of Vermont, has announced the names of 16 new members of the Teaching Academy.

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research in Baltimore, Md., and at the Vaccine Testing Center at the Larner College of Medicine at the University of Vermont in Burlington.

A study co-authored by Donald Leopold, M.D., UVM clinical professor of surgery, is co-focuses on phantom odors in aging Americans. According to the study, 1 in 15 Americans over the age of 40 experience smelling unpleasant scents with no apparent source.